Why generic Ozempic could soon become a lot cheaper in Quebec

The price of drugs like Ozempic may soon drop dramatically in Quebec after a patent expired, which experts predict could cause a surge in demand for the popular weight-loss medication. Ozempic, which belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, was approved for sale by Health Canada in 2018 to treat patients with Type 2 diabetes, but has exploded in popularity in recent years as a powerful weight-loss drug. Until now, medications containing semaglutide, w